Regulus Therapeutics, Inc.

Historical 13F Holders

Symbol
RGLS
CUSIP
75915K101
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 1 958 k $1.68 M
2021 Q2 1 0 $0
2021 Q1 2 16.0 $0
2020 Q4 2 16.0 $0
2020 Q3 2 16.0 $0
2020 Q2 2 16.0 $0
2020 Q1 2 16.0 $0
2019 Q4 1 16.0 $0
2019 Q3 1 16.0 $0
2019 Q2 1 16.0 $0
2019 Q1 1 16.0 $0
2018 Q4 1 16.0 $0
2018 Q3 37 38.0 M $35.1 M
2018 Q2 48 51.9 M $34.2 M
2018 Q1 53 53.1 M $38.1 M
2017 Q4 51 55.9 M $58.1 M
2017 Q3 51 61.7 M $77.2 M
2017 Q2 50 22.7 M $22.4 M
2017 Q1 61 20.1 M $33.2 M
2016 Q4 74 23.6 M $53.2 M
2016 Q3 88 26.5 M $87.4 M
2016 Q2 94 27.4 M $79.2 M
2016 Q1 107 34.3 M $237 M
2015 Q4 110 34.3 M $299 M
2015 Q3 97 34.6 M $226 M
2015 Q2 98 34.4 M $377 M
2015 Q1 95 32.8 M $555 M
2014 Q4 93 29.6 M $478 M
2014 Q3 51 14.6 M $99.6 M
2014 Q2 54 14.3 M $115 M
2014 Q1 55 14.2 M $128 M